Friday, 15 Dec 2017

You are here

RheumNow Week in Review – 12 August 2016

Highlights from this week on RheumNow.com include:

  1. ViDEO: Pearls on Methotrexate side effect management from Dr. Jack Cush at 2016 RNS meeting. Thanks to Healio! https://t.co/6zUJHRbbxF
  2. Great review of Raynauds Phenomenon in NEJM by Dr. Fred Wigley https://t.co/pzxpQlNQFH
  3. 10 Essential Facts about Seronegative #RA. It's the symptoms, not the labs that count most. 20% of RA is seronegative https://t.co/gEPqK3OXHT
  4. Walgreens establishes disposal “kiosk” for patients needing to discard old/dangerous/narcotic meds. . https://t.co/aDp5963Kq8 https://t.co/oigv282jZH
  5. In Japan, persistence on biologics highest in biologic-naïve (>95%) and older Pts & lowest w/ more comorbidities. https://t.co/4VTDOCpZeJ
  6. Should low-dose prednisone be used in Osteoarthritis? Conflicting data in RCTs https://t.co/7RhGFvGkD4 https://t.co/HKx7pi0K1s
  7. There are 3 kinds "hip pain" - 1 Buttock pain (70% from LS spine); 2. Side/trochanteric pain (20% from FM, Bursitis); 3. Anterior/groin (true hip Jt) (<10%)
  8. A single center 9 yr follow up study of 97 myositis saw 25% died, most from Infx(29%). Death increased w/ lung Dz (HR 1.8), infection (HR 4.2) https://t.co/c6Vp9BuN94
  9. There is No Added Lymphoma Risk with TNF Inhibitor Use
  10. Etanercept May Lower Alzheimers Risk in Rheumatoid Arthritis
  11. Cryptochromes Regulate Circadian Inflammation in RA
  12. 2016 EULAR Update to Gout Guidelines
  13. My Nurse Practitioner
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review - 8 December 2017

Dr. Jack Cush covers the news and journal articles published on RheumNow.comin the past week.

Rheumatology Year in Review

During 2017, the improvements and refinements seen during previous years in the treatment of rheumatoid arthritis have been extending to other conditions ranging from psoriatic arthritis to lupus and for both monoclonal antibodies and oral small molecule medications.

Advances for Biologics

The ACR17 RheumNow Week in Review - 1 December 2017

Dr Jack Cush reviews nighlights and news from the past 2 weeks on RheumNow.com. This week's report includes new drug approvals, disappointing ACR guidelines, Lyme & Zika, infertility, dermatomyositis skin outcomes and myositis-associated cancer testing.

ACR Clinical Guidelines Flawed by Low Evidence

JAMA Internal Medicine has reported that recommendations and clinical practice guidelines from the American College of Rheumatology are often based on expert opinion, but lack rigorous (grade A) evidence to support many of their recommendations. 

RheumNow ACR 2017 Awards

The Annual Meeting of the American College of Rheumatology is a gargantuan educational and professional event that is on nearly everyone's radar each year. RheumNow had an expansive effort to cover this meeting and you can review the work of our faculty at ACR17.RheumNow.com.  But we have decided to take this one step further and today we are announcing our 2017 RheumNow ACR Awards.